Table 1.
Parent Compound | Biotransformation Biocatalyst | Biological Activity Evaluated | Enzymatic Reaction | Effect on Biological Activity * | References |
---|---|---|---|---|---|
sclareolide | fungi | cytotoxicity in vitro | hydroxylation | enhance | [72] |
ingenol-3-angelate | plant cell cultures | cytotoxicity in vitro | Hydroxylation deacylation |
decrease decrease |
[66] |
ent-15α-hydroxy-kaur-16-en-19-oic | fungi | allelopathic | hydroxylation | enhance | [73] |
ent-8(14),15-pimaradiene | fungi | antibacterial | hydroxylation dihydroxylation |
enhance no effect |
[74] |
mulin-11,13-dien-20 oic acid | fungi | gastroprotective in vivo | hydroxylation dihydroxylation |
enhance enhance |
[75] |
20-deoxyingenol | fungi | cytotoxicity in vitro | hydroxylation | no effect | [81] |
13-oxyingenol dodecanoate | fungi | cytotoxicity in vitro | hydroxylation | decrease | [81] |
pseudolaric acid B | fungi | antifungal | conjugation with amino acids epimerization migration of double bond |
decrease decrease decrease |
[46] |
ent-trachyloban-18-oic acid | fungi | cytotoxicity in vitro | hydroxylation backbone rearrangement |
decrease decrease |
[80] |
(+)-(4R,5S,8R,9S)-18-hydroxy-ent-halima-1(10),13-(E)-dien-15-oic | fungi | anticholinesterase (Hr-AChE) | oxidation carboxylation hydroxylation |
enhance enhance enhance |
[55] |
cryptotanshinone | fungi | antiviral | Degradation and rearrangement | enhance | [54] |
16-oxacleroda-3,13(14)E-dien-15-oic acid | fungi | antifungal | hydroxylation | enhance | [82] |
trachyloban-19-oic acid | fungi | anticholinesterase | oxidation rearrangement |
enhance enhance |
[65] |
10-oxo-2R,5R,14β-triacetox-ytaxa-4(20),11(12)-diene | bacteria | tumor MDR reversal activity | hydroxylation dihydroxylation oxidation and acetalization |
no effect no effect enhance |
[59] |
deoxyandrographolide | fungi | LPS-induced NO production | oxidation of –OH to ketone hydroxylation epoxidation cleavage of the lactone |
enhance decrease decrease decrease |
[77] |
andrographolide | fungi | cytotoxicity in vitro | oxidation of –OH to ketone hydration epimerization |
decrease decrease enhance |
[56,57] |
* When compared to the parent compound.